VIR Vir Biotechnology, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon immediate Filed Jun 10, 2026 Processed 4d 13h ago SEC 0001628280-26-042237
8-K context-dependent: Items 5.02

Price Chart

Loading chart...

Executive Summary

Vir Biotechnology appointed Timothy Coughlin, CPA, as a new Class III director and Audit Committee Chair, expanding the board from 7 to 8 members. This is a routine governance change with no financial impact or strategic implications disclosed.

Actionable Insight

Routine board refresh with no operational or financial implications. No actionable trading signal; monitor upcoming quarterly filings for any strategic shifts.

Key Facts

  • Board expanded from 7 to 8 members; Timothy Coughlin appointed to fill new vacancy
  • Coughlin will serve as Class III director until 2028 annual meeting and as Audit Committee Chair
  • No arrangement or understanding with any person triggered the appointment; no related party transactions
  • Coughlin receives standard non-employee director compensation per existing policy, including stock option and RSU grants under the 2019 Equity Incentive Plan

Financial Impact

Standard director compensation; no material financial impact disclosed

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-042237
Document: 0001628280-26-042237-index-headers.html0001628280-26-042237
Document: 0001628280-26-042237-index.html0001628280-26-042237
Document: 0001628280-26-042237.txt0001628280-26-042237
14 reports for VIR
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
Type Now
Jun 10, 2026
4d ago
3
NEUTRAL ★ 1/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 10, 2026
4d ago
8-K
NEUTRAL ★ 2/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 2, 2026
12d ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $9.15▲ +4.33%▲ +3.93%$8.61 (−1.82%)
May 28, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$9.55 $9.54▼ −0.10%▼ −0.34%$8.61 (−9.84%)
Apr 16, 2026
8w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.75▲ +4.07%▲ +2.85%$8.61 (−16.65%)
Apr 10, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$9.31 $10.05▲ +7.95%▲ +6.74%$8.61 (−7.52%)
Apr 1, 2026
10w ago
Insider Cluster
BEARISH ★ 6/10
$9.02 $9.06▼ −0.44%▼ −0.36%$8.61 (+4.55%)
Mar 4, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$9.10 $9.55▲ +4.95%▲ +6.26%$8.61 (−5.38%)
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$9.49 $10.00▼ −5.37%▼ −4.54%$8.61 (+9.27%)
Feb 23, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$7.43 $9.49▼ −27.73%▼ −26.99%$8.61 (−15.88%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 3h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access